Clinical Trial Update: Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals [Phase 4]

View source ↗

Summary

Phase 4 trial comparing cobicistat-boosted versus ritonavir-boosted darunavir brain penetration in HIV-infected individuals was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Aids-related Dementia Complex
• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• PREZISTA (darunavir)
• Tybost (Cobicistat)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: AIDS-related Dementia Complex | Phase 4 | Status: TERMINATED